Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2010.02223.x/fullpdf
Reference60 articles.
1. 1. World Health Organization. Mortality database. Available at http://www.who.int/whosis/whostat/EN_WHS08_Part1.pdf (accessed 4 December 2008).
2. 2. El-Serag HB , Tran T , Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
3. 3. Bosetti C , Levi F , Boffetta P , et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008; 48: 137-45.
4. 4. Davila JA , Morgan RO , Shaib Y , McGlynn KA , El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case-control study. Gut 2005; 54: 533-9.
5. 5. El-Serag HB , Richardson PA , Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 2001; 96: 2462-7.
Cited by 264 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion;Cellular Oncology;2024-07-11
2. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06
3. Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: a systematic review and meta-analysis;European Journal of Gastroenterology & Hepatology;2024-03-11
4. From liver to hormones: The endocrine consequences of cirrhosis;World Journal of Gastroenterology;2024-03-07
5. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections;Journal of Cancer Metastasis and Treatment;2024-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3